Quartely Summary (Tables)

12 Months Ended

Jan. 27, 2013

Table Text Block Supplement [Abstract]

Schedule of Quarterly Financial Information [Table Text Block]

	Fiscal Year 2013 Quarters Ended
	January 27, 2013		October 28, 2012		July 29, 2012 (A)		April 29, 2012
	(In thousands, except per share data)
Statement of Income Data:
Revenue	$	1,106,902	$	1,204,110	$	1,044,270	$	924,877
Cost of revenue	$	521,300	$	567,452	$	503,551	$	461,513
Gross profit	$	585,602	$	636,658	$	540,719	$	463,364
Net income	$	173,973	$	209,080	$	119,046	$	60,437
Basic net income per share	$	0.28	$	0.34	$	0.19	$	0.10
Diluted net income per share	$	0.28	$	0.33	$	0.19	$	0.10

	Fiscal Year 2012 Quarters Ended
	January 29, 2012 (B)		October 30,  2011		July 31, 2011		May 1, 2011
	(In thousands, except per share data)
Statement of Income Data:
Revenue	$	953,194	$	1,066,180	$	1,016,517	$	962,039
Cost of revenue	$	463,181	$	509,463	$	491,233	$	477,536
Gross profit	$	490,013	$	556,717	$	525,284	$	484,503
Net income	$	116,025	$	178,273	$	151,573	$	135,219
Basic net income per share	$	0.19	$	0.29	$	0.25	$	0.23
Diluted net income per share	$	0.19	$	0.29	$	0.25	$	0.22

(A) Includes net present value of a $25 million charitable contribution pledged on June 12, 2012 to Stanford Hospital and Clinic, payable over a ten year period.

(B) Includes an additional charge of $7.3 million associated with the fair value prescribed to the settlement between us and Rambus. On February 7, 2012, we entered into a licensing agreement with Rambus and both parties also agreed to settle all outstanding legal disputes.